Evidence map›Paper›PMID 34152663›Full record

Observational studyJournal of the International AIDS Society2021

Trends in demographic and clinical characteristics and initiation of antiretroviral therapy among adult patients enrolling in HIV care in the Central Africa International epidemiology Database to Evaluate AIDS (CA-IeDEA) 2004 to 2018.

Adebola A Adedimeji, Donald R Hoover, Qiuhu Shi, Hae-Young Kim, Ellen Brazier, Jonathan Ross, Gad Murenzi, Christella Twizere, Patricia Lelo, Dominique Nsonde and 6 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Journal of the International AIDS Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 4 countries.

Adebola A AdedimejiDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY, USA.ORCID 0000-0002-8012-9124
Donald R HooverDepartment of Statistics, Rutgers University, Piscataway, NJ, USA.
Qiuhu ShiDepartment of Public Health, School of Health Sciences and Practice, New York Medical College, Valhalla, NY, USA.
Hae-Young KimDepartment of Public Health, School of Health Sciences and Practice, New York Medical College, Valhalla, NY, USA.
Ellen BrazierSchool of Public Health, City University of New York, New York, NY, USA.ORCID 0000-0002-8514-1958
Jonathan RossDepartment of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA.ORCID 0000-0001-6126-3048
Gad MurenziDivision of Clinical Education, Rwanda Military Hospital, Kanombe, Kigali, Rwanda.
Christella TwizereCentre National de Reference en Matière de VIH/SIDA, Bujumbura, Burundi.ORCID 0000-0003-1102-5564
Patricia LeloPediatric Hospital Kalembe Lembe, Kinshasa, Democratic Republic of Congo.
Dominique NsondeCTA Brazzaville, Brazzaville, Republic of Congo.
Rogers AjehClinical Research Education, Networking and Consultancy, Yaounde, Cameroon.
Anastase DzudieClinical Research Education, Networking and Consultancy, Yaounde, Cameroon.
Denis NashSchool of Public Health, City University of New York, New York, NY, USA.
Marcel YotebiengDepartment of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA.
Kathryn AnastosDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY, USA.
Central Africa IeDEA Consortium
Albert Einstein College of Medicine · USCity University of New York · USNew York Medical College · USCentre Hospitalier et Universitaire de Brazzaville · CGKinshasa General Hospital · CDRutgers, The State University of New Jersey · USRwanda Military Hospital · RW

Funding

"Enhancing Cancer Research in Central Africa IeDEA"U01AI096299 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Denis Nash, Marcel Yotebieng · 2011 to 2026
$35.8M
Minimizing losses from HIV care under universal treatment in RwandaK23MH114752 · NIMH · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI ROSS, JONATHAN · 2017 to 2021
$995k
NIAID NIH HHS U01 AI096299NIMH NIH HHS K23 MH114752
6 · The paper itself

Abstract

introductionThe Central Africa International epidemiology Database to Evaluate AIDS (CA-IeDEA) is an open observational cohort study investigating impact, progression and long-term outcomes of HIV/AIDS among people living with HIV (PLWH) in Burundi, Cameroon, Democratic Republic of Congo (DRC), Republic of Congo (ROC) and Rwanda. We describe trends in demographic, clinical and immunological characteristics as well as antiretroviral therapy (ART) use of patients aged > 15 years entering into HIV care in the participating CA-IeDEA site.

methodsInformation on sociodemographic characteristics, height, weight, body mass index (BMI), CD4 cell count, WHO staging and ART status at entry into care from 2004 through 2018 were extracted from clinic records of patients aged > 15 years enrolling in HIV care at participating clinics in Burundi, Cameroon, DRC, ROC and Rwanda. We assessed trends in patient characteristics at enrolment in HIV care including ART initiation within the first 30 days after enrolment in care and calculated proportions, means and medians (interquartile ranges) for the main variables of interest.

resultsAmong 69,176 patients in the CA-IeDEA cohort, 39% were from Rwanda, 24% from ROC, 18% from Cameroon, 14% from Burundi and 5% from DRC. More women (66%) than men enrolled in care and subsequently initiated ART. Women were also younger than men (32 vs. 38 years, P < 0.001) at enrolment and at ART initiation. Trends over time show increases in median CD4 cell count at enrolment from 190 cells/µL in 2004 to 334 cells/µL in 2018 at enrolment. Among those with complete data on CD4 counts (60%), women had a higher median CD4 cell count at care entry than men (229 vs. 249 cells/µL, P < 0.001). Trends in the proportion of patients using ART within 30 days of enrolment at the participating site show an increase from 16% in 2004 to 75% in 2018.

conclusionsTrends from 2004 to 2018 in the characteristics of patients participating in the CA-IeDEA cohort highlight improvements at entry into care and subsequent ART initiation including after the implementation of Treat All guidelines in the participating sites.

Indexed as

Acquired Immunodeficiency SyndromeAnti-HIV AgentsHIV InfectionsAdultAfrica, CentralAgedCD4 Lymphocyte CountDemographyFemaleHumansMaleAnti-HIV AgentsAfricaARVcohort studiesHIV care continuumHIV epidemiologylow- and middle-income countries

Identifiers

PMID34152663
PMCPMC8216247
OpenAlexW3175204147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.